1. A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim vs. Vancomycin in the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens (REVIVE-1). (4th October 2017) Authors: Huang, David; Mcleroth, Patrick; Shukla, Rajesh; File, Thomas M; Wilcox, Mark; Torres, Antoni; Liu, Alyssa; O'riordan, William; Overcash, Scott; Dryden, Matthew; Corey, G Ralph; Heller, Barry Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Outcomes with IV/oral Delafloxacin (DLX) Compared with Vancomycin/Aztreonam (VAN/AZ) in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Gram-negative (GN) Pathogens. (4th October 2017) Authors: O'Riordan, William; Overcash, Scott; Lawrence, Laura; McCurdy, Sandra P; Tseng, Carol; Cammarata, Sue K Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Outcomes with IV/oral Delafloxacin (DLX) Compared with Vancomycin/Aztreonam (VAN/AZ) in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Gram-positive (GP) Pathogens. (4th October 2017) Authors: Overcash, Scott; O'Riordan, William; Lawrence, Laura; McCurdy, Sandra P; Tseng, Carol; Cammarata, Sue K Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗